Bringing a wave of change to how kidney care is managed.
Patient drop-out prediction
We collect hundreds of data points throughout the patient journey and connect them to drug-testing results, allowing for the earlier detection of medication drop-out risks, which can be reported back to the HCP.
Discovery of novel digital biomarkers
By a similar methodology and connecting the data to remote or digital biomarker measurements, we can identify a set of data points as a novel biomarker that can provide accurate insights on the future progression of the disease.
Data-driven nudges towards better health
Based on the insights collected, we can create and validate personalized data-driven nudges that further enhance the adoption to the therapy and favourable behaviours, with in mind maximizing the chances of demonstrating better health outcomes.